TNFSF14 and neoplasm: Moreover, LIGHT-VTP decreases intravasation of tumour cells from the primary sites into the circulation, and also reverses vessel abnormalities and sensitizes tumours for checkpoint inhibitor antibodies against the PD-1 once metastatic nodules have formed [298].